Generatixe Inc. is at the forefront of bioengineering, leveraging the transformative power of generative AI models. Our cutting-edge technology enables the creation of advanced antibodies, nanobodies, mRNA sequences, gene therapies, and cell reprogramming platforms. We specialize in generative biology, meticulously optimizing every step of the development process, from designing innovative vectors for in vivo delivery of proteins, RNA, and DNA to enhancing therapeutic outcomes.
At Generatixe, we are revolutionizing biomedicine by merging artificial intelligence with biological insights. Our unique Bioinformed AI approach is tailored for scenarios with limited biodata availability, offering a streamlined alternative to traditional generative AI models. By integrating real-world biodata from verified laboratory experiments, we minimize computational processes while maximizing the accuracy and effectiveness of our solutions.
Join us as we reshape the future of healthcare through the synergy of AI and biology.
Company Details
- Founded
- -
- Address
- 6868 Nancy Ridge Dr, San Diego,california 92121,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.generatixe.com/
- Keywords
- Generative Biology, Generative AI, Generative RNA, Generative Cell, Generative DNA, Generative Protein, Generative Nanobody, Generative Antibody, Generative Vectors, Generative Gene.
- HQ
- San Diego, California
Generatixe, Inc. Questions
Generatixe, Inc.'s website is http://www.generatixe.com/
Generatixe, Inc.'s LinkedIn profile is https://www.linkedin.com/company/generatixe
Generatixe, Inc.'s industry is
Biotechnology Research
Generatixe, Inc.'s top competitors are
Infirmacea Inc.,
Novopyxis,
Soft Transport Biosystem Inc.,
Drinking,
Celid Biotechnologies Inc.,
Satreda As,
Space Medicine Inc.,
Navera,
Agro2oil,
Navera Therapeutics.
Generatixe, Inc.'s categories are Biotechnology Research
Generatixe, Inc.'s founding year is 2024
